Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
The Journal of Urology|December 22, 1999
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of gradeV B Lokeshwar, C Obek, H T Pham, et al.Gynecologic Oncology|October 1, 1991
Cell kinetic perturbations after irradiation and caffeine in the BG-1 ovarian carcinoma cell lineE H Wolloch, B U Sevin, J P Perras, et al.Urology|January 11, 1991
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study GroupM S Soloway, G Chodak, N J Vogelzang, et al.Urology|August 1, 1995
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study GroupN J Vogelzang, G W Chodak, M S Soloway, et al.Cancer|March 1, 1984
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepaB F Issell, G R Prout, M S Soloway, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata)A J Claflin, D L Vesely, J L Hudson, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 18, 2000
MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolithG N Sfakianakis, D J Cohen, R H Braunstein, et al.Cancer|November 15, 1996
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.Urology|September 25, 1997
Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.Pageof 9